Intrinsic Value of S&P & Nasdaq Contact Us

Stepan Company SCL NYSE

NYSE • Basic Materials • Chemicals - Specialty • US • USD

SharesGrow Score
55/100
3/7 Pass
SharesGrow Intrinsic Value
$265.21
+412.2%
Analyst Price Target
$75.00
+44.8%

Stepan Company (SCL) is a Chemicals - Specialty company in the Basic Materials sector, currently trading at $51.78. It has a SharesGrow Score of 55/100, indicating a above average investment profile with 3 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of SCL = $265.21 (+412.2% from the current price, the stock appears undervalued). Analyst consensus target is SCL = $75 (+44.8% upside).

Valuation: SCL trades at a trailing Price-to-Earnings (P/E) of 25 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.53.

Financials: revenue is $2.3B, -5.1%/yr average growth. Net income is $47M, growing at -18.1%/yr. Net profit margin is 2% (thin). Gross margin is 11.6% (-3.8 pp trend).

Balance sheet: total debt is $691M against $1.2B equity (Debt-to-Equity (D/E) ratio 0.56, moderate). Current ratio is 1.29 (adequate). Debt-to-assets is 29.3%. Total assets: $2.4B.

Analyst outlook: 3 / 3 analysts rate SCL as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 72/100 (Pass), Growth 15/100 (Fail), Past 100/100 (Pass), Health 33/100 (Fail), Moat 37/100 (Fail), Future 100/100 (Pass), Income 30/100 (Fail).

$75.00
▲ 44.84% Upside
Average Price Target
The 12-month price target for Stepan Company is $75.00.

SCL SharesGrow Score Overview

55/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 72/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 37/100
Gross margin is + market cap
FUTURE 100/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SCL

VALUE Pass
72/100
SCL trades at a trailing Price-to-Earnings (P/E) of 25 (S&P 500 average ~25). Forward PEG 0.53 — Peter Lynch undervalued (≤1.0). Trailing PEG 7.08. Analyst consensus target is $75, implying +44.8% from the current price $52. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Fail
15/100
SCL: -5.1%/yr revenue is, -18.1%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
SCL: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Fail
33/100
Balance sheet SCL: Debt-to-Equity (D/E) ratio 0.56 (moderate), Current ratio is 1.29 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Fail
37/100
SCL: Gross margin is 11.6% (-3.8 pp trend), $1B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 37/100. ≥ 70 = Pass.
View details →
FUTURE Pass
100/100
Analyst outlook: 3 / 3 analysts rate SCL as buy (100%). Analyst consensus target is $75 (+44.8% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
SCL: Net profit margin is 2%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range41.82-68
Volume84.96K
Avg Volume (30D)177.95K
Market Cap$1.17B
Beta (1Y)1.01
Dividend Yield$1.5600
Share Statistics
EPS (TTM)2.05
Shares Outstanding$22.87M
IPO Date1992-03-17
Employees2,396
CEOLuis E. Rojo
Financial Highlights & Ratios
Revenue (TTM)$2.33B
Gross Profit$269.89M
EBITDA$208.02M
Net Income$46.9M
Operating Income$68.9M
Total Cash$132.69M
Total Debt$691.04M
Net Debt$558.35M
Total Assets$2.36B
Price / Earnings (P/E)25.3
Price / Sales (P/S)0.5
Analyst Forecast
1Y Price Target$75.00
Target High$75.00
Target Low$75.00
Upside+44.8%
Rating ConsensusBuy
Analysts Covering3
Buy 100% Hold 0% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS8585861003

Price Chart

SCL
Stepan Company  ·  NYSE
Basic Materials • Chemicals - Specialty
41.82 52WK RANGE 68.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message